ERNA
ERNA
NASDAQ · Biotechnology

Ernexa Therapeutics Inc

$0.38
-0.30 (-44.66%)
As of Feb 8, 2:34 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 724.3K 759.7K 723.6K
Net Income -22,347 -24,634 -22,962
EPS
Profit Margin -3.1% -3.2% -3.2%
Rev Growth -7.8% +6.1% +6.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.15M 1.20M 1.05M
Total Equity 1.87M 1.80M 2.01M
D/E Ratio 0.62 0.67 0.52
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -36,678 -38,889 -37,851
Free Cash Flow -27,891 -29,815 -29,431